Zynerba Press Releases

12 May 21 Zynerba Pharmaceuticals Reports First Quarter 2021 Financial Results and Operating Highlights

5 May 21 Zynerba Pharmaceuticals Announces Phase 3 RECONNECT Trial Design for Zygel™ in Fragile X Syndrome

29 Apr 21 Zynerba Pharmaceuticals Presents Two Posters at the Society of Biological Psychiatry 2021 Virtual Meeting

15 Apr 21 Zynerba Pharmaceuticals Announces the Acceptance of Two Posters at the Society of Biological Psychiatry 2021 Virtual Meeting

6 Apr 21 Zynerba Pharmaceuticals to Present at the Needham Virtual Healthcare Conference

10 Mar 21 Zynerba Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights

4 Mar 21 Zynerba Pharmaceuticals to Participate in the 33rd Annual ROTH Conference

4 Jan 21 Zynerba Pharmaceuticals to Present at Two January Virtual Investor Conferences

17 Dec 20 Zynerba Pharmaceuticals Provides Regulatory Update on Zygel™ in Fragile X Syndrome

4 Dec 20 Zynerba Pharmaceuticals Presents New Data in Two Posters at the 2020 Annual Meeting of the American Epilepsy Society (AES)